Responses
Regular and young investigator award abstracts
Immuno-conjugates and chimeric molecules
621 A Tregs depleting, CD25-targeted antibody-drug conjugate synergizes with tumor-targeted radiotherapy and systemic interleukin-2 in pre-clinical models of solid cancers
Compose a Response to This Article
Other responses
No responses have been published for this article.
